版本:
中国

BRIEF-Sorrento Therapeutics to contribute immuno-oncology and cellular therapy intellectual property, assets to Celularity

June 13 Sorrento Therapeutics Inc-

* Sorrento Therapeutics - co, unit executed definitive agreement to contribute certain immuno-oncology and cellular therapy intellectual property, assets to Celularity Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐